We are live on ! Find out more
AIP

Arrowpoint Investment Partners Portfolio holdings

AUM $459M
1-Year Est. Return 93.97%
This Fund
S&P 500
This Quarter Est. Return
+33.31%
1 Year Est. Return
+93.97%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$459M
AUM Growth
+$347M
Cap. Flow
+$245M
Cap. Flow %
53.32%
Top 10 Hldgs %
63.7%
Holding
167
New
86
Increased
23
Reduced
20
Closed
38

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$30.6M
2
GS icon
Goldman Sachs
GS
+$30.2M
3
XOM icon
ExxonMobil
XOM
+$26.8M
4
GPN icon
Global Payments
GPN
+$26.4M
5
NVDA icon
NVIDIA
NVDA
+$25.8M

Top Sells

Rank Stock Value
1
ASX icon
ASE Group
ASX
+$3.89M
2
ASND icon
Ascendis Pharma A/S
ASND
+$2.71M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$2.01M
4
PFE icon
Pfizer
PFE
+$2M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.93M

Sector Composition

Rank Sector Weight
1 Miscellaneous 28.72%
2 Healthcare 18.58%
3 Financials 14.08%
4 Industrials 12.67%
5 Technology 12.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABSI icon
101
Absci
ABSI
$1.51B
$228K 0.05%
+19,712
New +$111K
ELVN icon
102
Enliven Therapeutics
ELVN
$4.35B
$228K 0.05%
+4,499
New +$191K
CRVS icon
103
Corvus Pharmaceuticals
CRVS
$1.21B
$226K 0.05%
+15,112
New +$210K
CAPR icon
104
Capricor Therapeutics
CAPR
$547M
$225K 0.05%
+9,342
New +$283K
MAZE
105
Maze Therapeutics
MAZE
$1.46B
$223K 0.05%
+7,465
New +$196K
CME icon
106
CME Group
CME
$101B
$221K 0.05%
+1,003
New +$277K
BE icon
107
Bloom Energy
BE
$74.5B
$221K 0.05%
+729
New +$187K
MA icon
108
Mastercard
MA
$507B
$213K 0.05%
+415
New +$207K
ABCL icon
109
AbCellera Biologics
ABCL
$3.7B
$213K 0.05%
+27,092
New +$132K
CSGP icon
110
CoStar Group
CSGP
$12.5B
$210K 0.05%
+7,425
New +$255K
OTIS icon
111
Otis Worldwide
OTIS
$27.1B
$208K 0.05%
+2,903
New +$217K
MLYS icon
112
Mineralys Therapeutics
MLYS
$2.49B
$206K 0.04%
+7,633
New +$209K
CLYM
113
Climb Bio
CLYM
$891M
$199K 0.04%
15,241
-9,349
-38% -$96.6K
SLN
114
Silence Therapeutics
SLN
$907M
$179K 0.04%
+16,334
New +$115K
TAL icon
115
TAL Education Group
TAL
$6.88B
$155K 0.03%
+16,233
New +$171K
CLF icon
116
Cleveland-Cliffs
CLF
$7.13B
$124K 0.03%
+13,176
New +$145K
LUMN icon
117
Lumen
LUMN
$6.98B
$91.7K 0.02%
+11,942
New +$105K
SNAP icon
118
Snap
SNAP
$9.25B
$90.3K 0.02%
+20,330
New +$111K
NWL icon
119
Newell Brands
NWL
$2.6B
$89.5K 0.02%
+14,584
New +$61.7K
PLUG icon
120
Plug Power
PLUG
$3.03B
$76.1K 0.02%
28,077
+16,869
+151% +$53K
XLI icon
121
State Street Industrial Select Sector SPDR ETF
XLI
$32.2B
$74.1K 0.02%
400
-2,900
-88% -$504K
JBLU icon
122
JetBlue
JBLU
$1.75B
$72.9K 0.02%
+12,725
New +$64.8K
AMC icon
123
AMC Entertainment Holdings
AMC
$2.37B
$70.7K 0.02%
+37,228
New +$64.1K
KOS icon
124
Kosmos Energy
KOS
$1.66B
$59.9K 0.01%
+28,404
New +$79.1K
CCC
125
CCC Intelligent Solutions
CCC
$4.42B
$56.9K 0.01%
+11,019
New +$54.5K
3 4
5
6 7

Similar funds

VIM
VELA Investment Management New Albany, Ohio $459M AUM 18.61% 1-Year Est. Return
AM
Atwater Malick Lancaster, Pennsylvania $459M AUM 37.25% 1-Year Est. Return
SSC
Syverson Strege & Co West Des Moines, Iowa $459M AUM 27.74% 1-Year Est. Return
RFN
RDA Financial Network Akron, Iowa $459M AUM 24.58% 1-Year Est. Return
PWS
Peterson Wealth Services South Ogden, Utah $459M AUM 42.99% 1-Year Est. Return
GCM
G2 Capital Management Columbus, Ohio $459M AUM 18.56% 1-Year Est. Return
CIM
Coleford Investment Management Toronto, Ontario, Canada $459M AUM 23.79% 1-Year Est. Return
RAG
RIA Advisory Group Des Moines, Iowa $460M AUM 29% 1-Year Est. Return

Arrowpoint Investment Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Arrowpoint Investment Partners held 167 positions worth $459M, up 308% from $113M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Arrowpoint Investment Partners deployed $245M of net new capital in Q2 2026, opening 86 new positions and adding to 23 existing holdings. Its largest new stake was Citigroup: 235,033 shares worth $32.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $2.01M trimmed.

  • Arrowpoint Investment Partners's largest Q2 2026 buy was Citigroup: 235,033 shares worth $32.9M.
  • Arrowpoint Investment Partners added most to Insmed in Q2 2026, an estimated $2.8M increase.
  • Arrowpoint Investment Partners's biggest Q2 2026 reduction was Ionis Pharmaceuticals, cutting an estimated $2.01M.
  • Arrowpoint Investment Partners fully exited ASE Group in Q2 2026, selling an estimated $3.89M.
  • Arrowpoint Investment Partners's ten largest holdings make up 64% of its $459M portfolio in Q2 2026.
  • Arrowpoint Investment Partners opened 86 new positions and closed 38 in Q2 2026.
  • Arrowpoint Investment Partners's portfolio value rose 308% quarter-over-quarter to $459M.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.